Statera Biopharma, Inc. (STAB)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Sep 9, 2026, 10:45 AM EST
Statera Biopharma Market Cap
Statera Biopharma has a market cap or net worth of $14.52 thousand as of September 10, 2026. Its market cap has increased by 100.01% in one year.
Market Cap
14.52K
Enterprise Value
n/a
Revenue
3.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since July 28, 2021, Statera Biopharma's market cap has decreased from 170.15M to 14.52K, a decrease of -99.99%. That is a compound annual growth rate of -83.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 14.52K | -33.33% |
| Dec 31, 2025 | 21.78K | 200.01% |
| Dec 31, 2024 | 7.26K | -83.33% |
| Dec 29, 2023 | 43.55K | -99.02% |
| Dec 30, 2022 | 4.44M | -93.99% |
| Dec 31, 2021 | 73.82M | -56.61% |
| Jul 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biostax | 21.53K |
| Nymox Pharmaceutical | 21.01K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Regenicin | 15.35K |
| NovAccess Global | 12.33K |
| ObsEva | 11.72K |
| Syros Pharmaceuticals | 10.73K |